{
    "DATE": " 1-JUN-1987 15:31:01.76",
    "TOPICS": [
        "acq"
    ],
    "PLACES": [
        "usa"
    ],
    "PEOPLE": [
        "reagan"
    ],
    "NEWID": "17763",
    "TEXT": {
        "TITLE": "PHARMACONTROL <PHAR.O> ACQUIRES REVCO UNIT",
        "DATELINE": "    ENGLEWOOD CLIFFS, N.J., June 1 - ",
        "BODY": "PharmaControl Corp said it\nacquired Private Formulations Inc from <Revco D.S. Inc> for six\nmln dlrs in cash, a 13,550,000 dlr promissory note and warrants\nto buy 200,000 PharmaControl common shares.\n    PharmaControl said the purchase price was financed, along\nwith one mln dlrs in working capital, through secured\ninstitutional financing.\n    The company said betweenm 11,550,000 dlrs and 12,550,000\ndlrs f the principal amount of the Revco note, plus accrued\ninterest, is payable June 30. The balance is payable over three\nyears.\n    PharmaControl said it expects to make the payment due to\nRevco from proceeds of a proposed offering of units consisting\nof convertible subordinated debenturers and common stock\ncurrently on file with the Securities and Exchange Commission.\n    Upon closing of the public offering, the company said, it\nexpects the secured institutional financing to increase to a\ntotal of 12 mln dlrs.\n    Private Formulations is primarily engaged in the\nmanufacture and distribution of vitamins and private label\nover-the-counter pharmaceutical products.\n Reuter\n\u0003"
    },
    "ORGS": [
        "ec"
    ],
    "EXCHENGES": [
        "lme"
    ]
}